Analyst Says Acelyrin (SLRN) Dosing Errors Create Too Much Uncertainty, Securities Class Action Pending - Hagens Berman

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages SLRN Investors with Substantial Losses to Contact FirmSan Francisco, California--(Newsfile Cor...

Related Keywords

San Francisco ,California ,United States ,Hagens Berman ,Reed Kathrein ,Fargo Derek Archila ,California Newsfile Corp ,Acelyrin Inc ,Losses To Contact Firm ,Nasdaq ,Substantial Losses ,Plaintiff Deadline ,Securities Fraud Class Action ,Wells Fargo ,Derek Archila ,